Immune mechanisms of protection against mycobacterium tuberculosis center (IMPAC-TB)
Active Definitive Contract Awarded Last action
- Contract number
- 75N93019C00070
- Awardee
-
Seattle Children's Hospital UEI SZ32VTCXM799
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $90,532,553
Award facts
- Opportunity
-
- BAANIAIDNIHAI201700104 Solicitation number
- Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc-TB) Award Notice · Posted Jan 25, 2018
- Contract value 100% obligated
- $90,532,553.00 Current and potential, with all options
- Completion date 89% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Seattle, WA 98101, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $3,934,592 | |
| Other Administrative Action | $0 | |
| Change Order | $4,805,147 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $15,303,236 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $14,317,798 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $13,601,743 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $13,001,420 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $554,910 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $11,541,977 | |
| Modification | $13,471,730 | |
| Other Administrative Action | $0 |
Show all 27
About this award
The National Institute of Allergy and Infectious Diseases awarded a $90.532 million definitive contract to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) for the Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) on September 30, 2019, with ultimate completion September 29, 2027, under cost-no-fee pricing and no set-aside.
Place of performance is Seattle, WA 98101. The originating solicitation and Executive Order 14398 direct the consortium to identify immune responses capable of controlling or eradicating Mycobacterium tuberculosis through integrated analyses of tissue-specific and systemic immunity across mice, non-human primates, and humans, informing rational TB vaccine design. The multi-institutional research effort operates as a coordinating center spanning domestic and international locations, with primary subcontractors including Oregon Health & Science University, University of Washington, Fred Hutchinson Cancer Center, University of Massachusetts, Beth Israel Deaconess Medical Center, Stellenbosch University (South Africa), University of Minnesota, University of Alabama at Birmingham, Africa Health Research Institute (South Africa), London School of Hygiene and Tropical Medicine (UK), and Akagera Medicines. Work encompasses household contact studies, bronchoscopy coordination, human immunologic studies, non-human primate vaccine efficacy testing, mouse model development, transcriptomics and epigenetic analysis, spatial imaging of lung granulomas, and data resource management across seven fiscal years.
Service Contract Inventory reporting shows FY2025 invoiced labor of $14.6 million across 56.2 FTEs and 116,857 contractor hours, with a blended government-paid rate of $124.92 per hour. Subcontractors accounted for 85 percent of contractor hours in FY2025 across 24 named partners. Invoiced amounts rose from $2.7 million (FY2020) to $14.6 million (FY2025), reflecting the multi-year research consortium's growing operational scale.
Subawards
Show all 34
Quick answers
Who was awarded contract 75N93019C00070?
75N93019C00070 was awarded to Seattle Children's Hospital by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2019.
How much is contract 75N93019C00070 worth?
The government has obligated $90,532,553 on 75N93019C00070.
Was contract 75N93019C00070 competed?
The extent of competition for 75N93019C00070 was full and open competition. The government received 12 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award